Abstract 862: Atypical protein kinase c inhibitors can repress epithelial to mesenchymal transition (type III) in malignant melanoma | Citedby Results | Cancer Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Abstract 862: Atypical protein kinase c inhibitors can repress epithelial to mesenchymal transition (type III) in malignant melanoma

Cancer Res (2017) 77 (13_Supplement): 862.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

FOXO1 regulates oncogenic PKC-ι expression in melanoma inversely to c-Jun in an autocrine manner via IL-17E and ICAM-1 activation

WISHRAWANA RATNAYAKE
CHRISTOPHER APOSTOLATOS
SLOAN BREEDY
ANDRE APOSTOLATOS
MILDRED ACEVEDO-DUNCAN

World Academy of Sciences Journal (2018)

Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors

Wishrawana S. Ratnayake
Christopher A. Apostolatos
André H. Apostolatos
Ryan J. Schutte
Monica A. Huynh
David A. Ostrov
Mildred Acevedo-Duncan

Cell Adhesion & Migration 1.

FOXO1 regulates oncogenic PKC-ι expression in melanoma inversely to c-Jun in an autocrine manner via IL-17E and ICAM-1 activation

WISHRAWANA RATNAYAKE
CHRISTOPHER APOSTOLATOS
SLOAN BREEDY
ANDRE APOSTOLATOS
MILDRED ACEVEDO-DUNCAN

World Academy of Sciences Journal (2018)

World Academy of Sciences Journal ()